Milano Furuta - 01 Jul 2026 Form 4 Insider Report for TAKEDA PHARMACEUTICAL CO LTD (TAK)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Jul 2026, 18:09:03 UTC
Prior SEC filing
28 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Samuel Ntonme, by power of attorney, for Milano Furuta

Key filing fact

Milano Furuta filed Form 4 for TAKEDA PHARMACEUTICAL CO LTD (TAK) on 06 Jul 2026.

Key facts

  • This page summarizes Milano Furuta's Form 4 filing for TAKEDA PHARMACEUTICAL CO LTD (TAK).
  • 5 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 06 Jul 2026, 18:09.

Change

  • Previous filing in this sequence was filed on 28 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002111400 Primary reporting owner

Furuta Milano

Relationship
Chief Financial Officer, Director
Address
1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, JAPAN
Signature
/s/ Samuel Ntonme, by power of attorney, for Milano Furuta
Signature date
06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TAK transaction

Ordinary Shares

Award

Transaction value
Shares
+12,300
Change %
+21%
Price
$0.000000*
Shares after
70,200
Date
01 Jul 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TAK transaction Derivative

Tax Obligation Award

Disposed to Issuer

Transaction value
Shares
-16,619
Change %
-100%
Price
$4931.50*
Shares after
0
Date
10 Jul 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
16,619
Exercise price
Footnotes
F2, F3
TAK transaction Derivative

Tax Obligation Award

Award

Transaction value
Shares
+4,288
Change %
+58%
Price
$0.000000*
Shares after
11,741
Date
01 Jul 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
4,288
Exercise price
Footnotes
F4
TAK transaction Derivative

Tax Obligation Award

Award

Transaction value
Shares
+4,288
Change %
+102%
Price
$0.000000*
Shares after
8,482
Date
01 Jul 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
4,288
Exercise price
Footnotes
F4
TAK transaction Derivative

Tax Obligation Award

Award

Transaction value
Shares
+4,288
Change %
Price
$0.000000*
Shares after
4,288
Date
01 Jul 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
4,288
Exercise price
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest in three equal annual installments beginning on June 1, 2027.

Footnote F2

Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10.

Footnote F3

The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,882 to JPY 5,050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F4

Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .